Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Proqr Therapeutics (PRQR)

Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ProQR: Q2 Earnings Snapshot AP - Fri Aug 14, 11:46AM CDT

ProQR: Q2 Earnings Snapshot

PRQR : 2.35 (-1.26%)
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors GlobeNewswire - Thu Apr 30, 7:00AM CDT

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company...

PRQR : 2.35 (-1.26%)
ProQR: Q4 Earnings Snapshot AP - Thu Mar 12, 8:18AM CDT

ProQR: Q4 Earnings Snapshot

PRQR : 2.35 (-1.26%)
ProQR Announces Year End 2025 Operating and Financial Results GlobeNewswire - Thu Mar 12, 6:00AM CDT

Advancing AX-0810 through ongoing Phase 1 dosing, with target engagement data expected 1H 2026Selected Development Candidates AX-2402 for Rett syndrome...

PRQR : 2.35 (-1.26%)
ProQR: Q3 Earnings Snapshot AP - Thu Nov 6, 2025

ProQR: Q3 Earnings Snapshot

PRQR : 2.35 (-1.26%)
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 GlobeNewswire - Mon Oct 20, 2025

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to...

PRQR : 2.35 (-1.26%)
Citizens JMP Sticks to Their Buy Rating for ProQR (PRQR) Tipranks - Thu Oct 16, 2025

Citizens JMP analyst Jonathan Wolleben reiterated a Buy rating on ProQR today and set a price target of $8.00. The company’s shares closed yesterday at $2.46.Elevate Your Investing Strategy: Take advantage...

PRQR : 2.35 (-1.26%)
ProQR to Participate in Upcoming Investor Conferences in October 2025 GlobeNewswire - Mon Oct 13, 2025

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to...

PRQR : 2.35 (-1.26%)
ProQR: Q2 Earnings Snapshot AP - Fri Aug 8, 2025

ProQR: Q2 Earnings Snapshot

PRQR : 2.35 (-1.26%)
ProQR: Q1 Earnings Snapshot AP - Fri May 9, 2025

ProQR: Q1 Earnings Snapshot

PRQR : 2.35 (-1.26%)

Barchart Exclusives

Nvidia Reports $7.8 Billion in Q2 Gains on Equity Portfolio That Includes SpaceX, Intel, CoreWeave, and More Barchart - Wed Aug 26, 8:06PM CDT
CFO Colette Kress has a different view than critics who accuse the chip giant of ‘circular financing,’ per her comments on the earnings call. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.